Skip to content
GenoLensGenoLens

BMPR1A

Chr 10q23.2

bone morphogenetic protein receptor type 1A

Aliases:
ALK3, CD292
MANE:
ENST00000372037.8

Annotations refreshed 1 month ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • Adult solid tumours cancer susceptibility

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Adult solid tumours for rare disease

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Childhood solid tumours

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Childhood solid tumours cancer susceptibility

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Colorectal cancer pertinent cancer susceptibility

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
  • GI tract tumours

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
  • Inherited polyposis and early onset colorectal cancer - germline testing

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Structural eye disease

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

+1 more panels — install the extension to see the full list inline on any page.

Disease associations (Open Targets)

  • juvenile polyposis syndrome

    0.83
  • hereditary mixed polyposis syndrome

    0.73
  • generalized juvenile polyposis/juvenile polyposis coli

    0.64
  • Inherited cancer-predisposing syndrome

    0.58
  • hereditary neoplastic syndrome

    0.58
  • bone disorder

    0.46
  • familial colorectal cancer type X

    0.46
  • neurodegenerative disease

    0.42
  • colorectal cancer

    0.38
  • tibia fracture

    0.37

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Bone morphogenetic protein receptor type-1A

On ligand binding, forms a receptor complex consisting of two type II and two type I transmembrane serine/threonine kinases. Type II receptors phosphorylate and activate type I receptors which autophosphorylate, then bind and activate SMAD transcriptional regulators. Receptor for BMP2, BMP4, GDF5 and GDF6. Positively regulates chondrocyte differentiation through GDF5 interaction. Mediates induction of adipogenesis by GDF6. May promote the expression of HAMP, potentially via its interaction with BMP2 (By similarity)

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.